Abstract: Provided is a carbon dioxide fluidity control device comprising, a sample preparation tank, a high-pressure stirring unit, a reciprocating plunger pump and a booster pump, wherein the stirring unit comprises one or more high-pressure stirring tanks, each provided with an atomizing spray probe and a piston, wherein a discharge port of the sample preparation tank is connected to the atomizing spray probe via a plunger pump, which is connected to the piston to push the piston to reciprocate; the booster pump is connected to the high-pressure stirring tanks to provide supercritical carbon dioxide to the high-pressure stirring tank; and a discharge port of the high-pressure stirring tanks is connected to an oilfield well group. Provided is a carbon dioxide fluidity control method using the device, comprising mixing surfactants and nanoparticles with heated carbon dioxide, and injecting a microemulsion of supercritical carbon dioxide and nano-silicon dioxide into an oilfield well group.

Abstract: Embodiments of the present disclosure relate to a permission setting method and apparatus, a device, and a medium. The method includes: displaying a permission customization control, in response to a trigger operation on a permission setting object of task information, the permission setting object including a first information object and/or a second information object, the second information object being subordinate to the first information object; displaying a permission editing interface, in response to a trigger operation on the permission customization control, and receiving customization permission information via the permission editing interface; and displaying the customization permission information corresponding to the permission setting object. Therefore, a hierarchy structure based on the task information satisfies a setting need for content-based permission customization, and improves a permission management efficiency.

Abstract: A bicyclic compound acting as a ROR? inhibitor. Provided are a compound of formula (I) or a pharmaceutically acceptable salt thereof, the compound having a structure as represented by formula (I-A) or formula (I-B). The provided compound of formula (I-A) or formula (I-B) or pharmaceutically acceptable salt thereof has good ROR? inhibitory activities, being expected to be used for treating diseases mediated by ROR? receptors in a mammal.

Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.

Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: A bicyclic compound acting as a ROR? inhibitor. Provided are a compound of formula (I) or a pharmaceutically acceptable salt thereof, the compound having a structure as represented by formula (I-A) or formula (I-B). The provided compound of formula (I-A) or formula (I-B) or pharmaceutically acceptable salt thereof has good ROR? inhibitory activities, being expected to be used for treating diseases mediated by ROR? receptors in a mammal.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electro-chromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.

Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electrochromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.

Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electrochromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.

Abstract: Curable liquid nano-composites for additive manufacturing of lenses are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments, the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include optical lenses such as both prescription and non-prescription ophthalmic lenses.

Abstract: A semiconductor device is disclosed that comprises a first non-volatile memory cell, a second non-volatile memory cell, an active region between the first and second memory cells, and an electrically conductive contact touching the active region, wherein the contact has a horizontal cross-section that is at least five percent smaller in a first dimension than in a second dimension.

Abstract: A semiconductor device is disclosed that comprises a first non-volatile memory cell, a second non-volatile memory cell, an active region between the first and second memory cells, and an electrically conductive contact touching the active region, wherein the contact has a horizontal cross-section that is at least five percent smaller in a first dimension than in a second dimension.